KRAS and neoplasm: Likewise, miR-143, which is frequently deregulated in pancreatic cancers, has been shown to interact with KRAS [37] and restitution of tumor suppressor miRNA may inhibit tumor growth in xenograft pancreatic cancer model using nanovector delivery of miR-143/145 [38].